Evaluation of prognostic markers in patients infected with SARS-CoV-2

Prognostic markers are the biomarkers used to measure the disease progression and patient outcome regardless of treatment in coronavirus disease 2019 (COVID-19). This study aimed to analyze laboratory parameters as prognostic markers for the early identification of disease severity. In this study, 1...

Full description

Bibliographic Details
Main Authors: Mandal Dipendra Kumar, Chhusyabaga Mandira, Pokhrel Sushant, Bhattarai Bibek Raj, Aryal Suraj, Nepal Richa, Bastola Anup, Baral Soma Kanta, Bhatt Mahendra Prasad, Marahatta Sujan Babu, Sah Shiv Kumar
Format: Article
Language:English
Published: De Gruyter 2022-10-01
Series:Open Life Sciences
Subjects:
Online Access:https://doi.org/10.1515/biol-2022-0502
_version_ 1811194144593281024
author Mandal Dipendra Kumar
Chhusyabaga Mandira
Pokhrel Sushant
Bhattarai Bibek Raj
Aryal Suraj
Nepal Richa
Bastola Anup
Baral Soma Kanta
Bhatt Mahendra Prasad
Marahatta Sujan Babu
Sah Shiv Kumar
author_facet Mandal Dipendra Kumar
Chhusyabaga Mandira
Pokhrel Sushant
Bhattarai Bibek Raj
Aryal Suraj
Nepal Richa
Bastola Anup
Baral Soma Kanta
Bhatt Mahendra Prasad
Marahatta Sujan Babu
Sah Shiv Kumar
author_sort Mandal Dipendra Kumar
collection DOAJ
description Prognostic markers are the biomarkers used to measure the disease progression and patient outcome regardless of treatment in coronavirus disease 2019 (COVID-19). This study aimed to analyze laboratory parameters as prognostic markers for the early identification of disease severity. In this study, 165 patients attending Sukraraj Tropical and Infectious Disease Hospital with COVID-19 were enrolled and divided into severe and non-severe groups. The demographic data, underlying co-morbidities, and laboratory findings were analyzed and compared between severe and non-severe cases. The correlation between the disease criticality and laboratory parameters was analyzed. Cut-off values of parameters for severe patients were speculated through the receiver operating characteristics (ROC) curve, and regression analysis was performed to determine the risk factors. Patients with severe COVID-19 infection had significantly higher absolute neutrophil count, neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), ferritin, positive carbohydrate reactive protein (CRP), glucose, urea, creatinine, and aspartate aminotransferase, while lower absolute lymphocyte count, absolute eosinophil count (AEC), and red blood cell count in comparison to non-severe infection. ROC analysis gave a cut-off value (sensitivity, specificity) of age, AEC, NLR, PLR, and ferritin as 47.5 years (70.2, 64.7%), 335 cells/mm3 (74, 67%) 3.3 (68.4, 63.7%), 129 (77.2, 51%), and 241 ng/mL (74.0%, 65.0%) respectively. Risk factor analysis showed higher age, low AEC, high ferritin, and positive CRP as independent risk factors associated with severe COVID-19 infection. Hematological and inflammatory markers, including novel NLR and PLR, should be assessed to aid clinicians in the early identification of severe cases, prioritization of cases, and effective management to decrease the mortality of COVID-19 patients.
first_indexed 2024-04-12T00:20:59Z
format Article
id doaj.art-39adef7ad62943599bbd5d16840dd71d
institution Directory Open Access Journal
issn 2391-5412
language English
last_indexed 2024-04-12T00:20:59Z
publishDate 2022-10-01
publisher De Gruyter
record_format Article
series Open Life Sciences
spelling doaj.art-39adef7ad62943599bbd5d16840dd71d2022-12-22T03:55:43ZengDe GruyterOpen Life Sciences2391-54122022-10-011711360137010.1515/biol-2022-0502Evaluation of prognostic markers in patients infected with SARS-CoV-2Mandal Dipendra Kumar0Chhusyabaga Mandira1Pokhrel Sushant2Bhattarai Bibek Raj3Aryal Suraj4Nepal Richa5Bastola Anup6Baral Soma Kanta7Bhatt Mahendra Prasad8Marahatta Sujan Babu9Sah Shiv Kumar10Department of Lab Medicine, Sukraraj Tropical and Infectious Diseases Hospital, Teku, G.P.O. Box: 15201, Soalteemode, Kathmandu, NepalDepartment of Laboratory Medicine, Manmohan Memorial Institute of Health Sciences, Kathmandu, NepalDepartment of Laboratory Medicine, Manmohan Memorial Institute of Health Sciences, Kathmandu, NepalDepartment of Laboratory Medicine, Manmohan Memorial Institute of Health Sciences, Kathmandu, NepalDepartment of Laboratory Medicine, Manmohan Memorial Institute of Health Sciences, Kathmandu, NepalDepartment of Lab Medicine, Sukraraj Tropical and Infectious Diseases Hospital, Teku, G.P.O. Box: 15201, Soalteemode, Kathmandu, NepalDepartment of Lab Medicine, Sukraraj Tropical and Infectious Diseases Hospital, Teku, G.P.O. Box: 15201, Soalteemode, Kathmandu, NepalDepartment of Laboratory Medicine, Manmohan Memorial Institute of Health Sciences, Kathmandu, NepalDepartment of Laboratory Medicine, Manmohan Memorial Institute of Health Sciences, Kathmandu, NepalDepartment of Laboratory Medicine, Manmohan Memorial Institute of Health Sciences, Kathmandu, NepalDepartment of Pharmacy, Purbanchal University, Little Buddha College of Health Science, Minbhawan, Kathmandu, NepalPrognostic markers are the biomarkers used to measure the disease progression and patient outcome regardless of treatment in coronavirus disease 2019 (COVID-19). This study aimed to analyze laboratory parameters as prognostic markers for the early identification of disease severity. In this study, 165 patients attending Sukraraj Tropical and Infectious Disease Hospital with COVID-19 were enrolled and divided into severe and non-severe groups. The demographic data, underlying co-morbidities, and laboratory findings were analyzed and compared between severe and non-severe cases. The correlation between the disease criticality and laboratory parameters was analyzed. Cut-off values of parameters for severe patients were speculated through the receiver operating characteristics (ROC) curve, and regression analysis was performed to determine the risk factors. Patients with severe COVID-19 infection had significantly higher absolute neutrophil count, neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), ferritin, positive carbohydrate reactive protein (CRP), glucose, urea, creatinine, and aspartate aminotransferase, while lower absolute lymphocyte count, absolute eosinophil count (AEC), and red blood cell count in comparison to non-severe infection. ROC analysis gave a cut-off value (sensitivity, specificity) of age, AEC, NLR, PLR, and ferritin as 47.5 years (70.2, 64.7%), 335 cells/mm3 (74, 67%) 3.3 (68.4, 63.7%), 129 (77.2, 51%), and 241 ng/mL (74.0%, 65.0%) respectively. Risk factor analysis showed higher age, low AEC, high ferritin, and positive CRP as independent risk factors associated with severe COVID-19 infection. Hematological and inflammatory markers, including novel NLR and PLR, should be assessed to aid clinicians in the early identification of severe cases, prioritization of cases, and effective management to decrease the mortality of COVID-19 patients.https://doi.org/10.1515/biol-2022-0502covid-19severitynlrplrcrp
spellingShingle Mandal Dipendra Kumar
Chhusyabaga Mandira
Pokhrel Sushant
Bhattarai Bibek Raj
Aryal Suraj
Nepal Richa
Bastola Anup
Baral Soma Kanta
Bhatt Mahendra Prasad
Marahatta Sujan Babu
Sah Shiv Kumar
Evaluation of prognostic markers in patients infected with SARS-CoV-2
Open Life Sciences
covid-19
severity
nlr
plr
crp
title Evaluation of prognostic markers in patients infected with SARS-CoV-2
title_full Evaluation of prognostic markers in patients infected with SARS-CoV-2
title_fullStr Evaluation of prognostic markers in patients infected with SARS-CoV-2
title_full_unstemmed Evaluation of prognostic markers in patients infected with SARS-CoV-2
title_short Evaluation of prognostic markers in patients infected with SARS-CoV-2
title_sort evaluation of prognostic markers in patients infected with sars cov 2
topic covid-19
severity
nlr
plr
crp
url https://doi.org/10.1515/biol-2022-0502
work_keys_str_mv AT mandaldipendrakumar evaluationofprognosticmarkersinpatientsinfectedwithsarscov2
AT chhusyabagamandira evaluationofprognosticmarkersinpatientsinfectedwithsarscov2
AT pokhrelsushant evaluationofprognosticmarkersinpatientsinfectedwithsarscov2
AT bhattaraibibekraj evaluationofprognosticmarkersinpatientsinfectedwithsarscov2
AT aryalsuraj evaluationofprognosticmarkersinpatientsinfectedwithsarscov2
AT nepalricha evaluationofprognosticmarkersinpatientsinfectedwithsarscov2
AT bastolaanup evaluationofprognosticmarkersinpatientsinfectedwithsarscov2
AT baralsomakanta evaluationofprognosticmarkersinpatientsinfectedwithsarscov2
AT bhattmahendraprasad evaluationofprognosticmarkersinpatientsinfectedwithsarscov2
AT marahattasujanbabu evaluationofprognosticmarkersinpatientsinfectedwithsarscov2
AT sahshivkumar evaluationofprognosticmarkersinpatientsinfectedwithsarscov2